Canada markets close in 1 hour 30 minutes

Immix Biopharma, Inc. (IMMX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.4200+0.0700 (+2.98%)
As of 02:07PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 62.03M
Enterprise Value 43.02M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.78
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.76

Trading Information

Stock Price History

Beta (5Y Monthly) 0.05
52-Week Change 3-2.53%
S&P500 52-Week Change 322.38%
52 Week High 37.7500
52 Week Low 31.4000
50-Day Moving Average 32.8378
200-Day Moving Average 33.5171

Share Statistics

Avg Vol (3 month) 3212.93k
Avg Vol (10 day) 3104.22k
Shares Outstanding 526.4M
Implied Shares Outstanding 626.4M
Float 814.09M
% Held by Insiders 145.90%
% Held by Institutions 18.65%
Shares Short (Apr 15, 2024) 4349.89k
Short Ratio (Apr 15, 2024) 42.37
Short % of Float (Apr 15, 2024) 41.79%
Short % of Shares Outstanding (Apr 15, 2024) 41.33%
Shares Short (prior month Mar 15, 2024) 4316.56k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-57.92%
Return on Equity (ttm)-106.23%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -16.14M
Net Income Avi to Common (ttm)-15.43M
Diluted EPS (ttm)-0.8900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.51M
Total Cash Per Share (mrq)0.66
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.32
Book Value Per Share (mrq)0.82

Cash Flow Statement

Operating Cash Flow (ttm)-11.37M
Levered Free Cash Flow (ttm)-5.94M